Automate Your Wheel Strategy on INCR
With Tiblio's Option Bot, you can configure your own wheel strategy including INCR - and automate your put writes, covered calls, and full wheel strategy. Just connect one of the supported brokerages: tastytrade, Schwab, TradeStation or Tradier and go.
Start Your Free Trial NowKey Metrics & Ratings
- symbol INCR
- Rev/Share 4.0074
- Book/Share 9.0557
- PB 0.5865
- Debt/Equity 0.5325
- CurrentRatio 1.7279
- ROIC -0.1414
- MktCap 289019909.43
- FreeCF/Share 0.0
- PFCF 0.0
- PE -3.3984
- Debt/Assets 0.2772
- DivYield 0
- ROE -0.1639
- Rating C-
- Score 1
- Recommendation Strong Sell
- P/E Score 1
- DCF Score 1
- P/B Score 4
- D/E Score 1
Recent Analyst Ratings
| Type | Ticker | Analyst Firm | Previous Rating | Current Rating | Previous Price Target | Current Price Target | Date |
|---|---|---|---|---|---|---|---|
| No ratings available. | |||||||
News
InterCure Announces Strategic Acquisition of ISHI, Unlocking Access to Premium U.S. Cannabis Technology and Brands
INCR
Published: September 19, 2025 by: GlobeNewsWire
Sentiment: Neutral
Published: September 19, 2025 by: GlobeNewsWire
Sentiment: Neutral
Acquisition of leading cannabis company marks major milestone in InterCure's commercial expansion strategy, bringing access to premium American brands and state-of-the-art cultivation technologies
Read More
About InterCure Ltd. (INCR)
- IPO Date 2019-01-28
- Website https://www.intercure.co
- Industry Drug Manufacturers - Specialty & Generic
- CEO Alexander Rabinovich
- Employees 320
InterCure Ltd., together with its subsidiaries, engages in the research, cultivation, production, marketing, and distribution of medical cannabis products in Israel and internationally. It offers dried cannabis inflorescences and cannabis extract mixed with oil. The company also invests in biomed sector. InterCure Ltd. was incorporated in 1994 and is headquartered in Herzliya, Israel.